Jefferies reiterated a Buy on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) and raised its price target to $46.00 (from $44.00).

This article: 135 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE